October 16, 2007 – Medtronic Inc. said in a statement that it has voluntarily suspended worldwide distribution of the Sprint Fidelis family of defibrillation leads because of the potential for lead fractures, and the company recommends that physicians do no perform new implants of the leads (Sprint Fidelis Models: 6930, 6931, 6948, 6949).
Safe medication administration at the hospital bedside is not simply a matter of a nurse handing out the right meds at the right time and to the right patient, of course. Today, the practice is a cooperative effort between the nursing staff and the pharmacy working to maximize the benefits of information technology solutions, such as bar coding and wireless.
October 16, 2007 - Abiomed Inc. will be presenting clinical data on Impella 2.5 percutaneous Ventricular Assist Device ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Despite advances in our understanding of the pathophysiology of pain and the pharmacology of analgesic drugs, as well as increasing emphasis on adequate pain management [1], pain control remains inadequate in hospitalized patients.
October 16, 2007 — In response to Medtronic’s decision to voluntarily suspend its Sprint Fidelis defibrillation leads, the Heart Rhythm Society (HRS) made a statement to underscore the importance of the society’s task force recommendations for the surveillance, analysis and performance reporting of pacemakers and implantable cardioverter defibrillators (ICDs).
October 16, 2007 - MIV Therapeutics Inc., a developer of coatings and drug delivery systems for cardiovascular stents ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
October 15, 2007 - Oncologists need to consider the affects on the cardiovascular system when treating early breast cancer, according to a review article in the Oct. 9 issue of the Journal of the American College of Cardiology.
October 15, 2007 - Siemens Medical Solutions Molecular Imaging Division will introduce the new Symbia E series single ...
October 15, 2007 - Low-dose coronary CT angiogram (CCTA) could be better for testing asymptomatic patients for heart attack risk, according to researchers at Cedars-Sinai Medical Center, Los Angeles, CA.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Siemens Medical Solutions Molecular Imaging Division's Symbia E series single photon emission computed tomography (SPECT ...
October 10, 2007 - Medtronic Inc. announced that an FDA advisory committee has recommended the Endeavor drug-eluting ...
October 11, 2007 - GE Healthcare, a unit of General Electric Company, today announced that it has completed the ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 10, 2007 - Premier Purchasing Partners, LP, announced new agreements have been awarded for diagnostic imaging ...
Carestream Health’s KODAK DIRECTVIEW CR Mammography feature adds mammography applications to its CR platforms along with ...
October 10, 2007 - A new technique for capturing images of chest veins eases diagnosis of venous diseases, according to ...
October 15, 2007
